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Abstract
During human nucleotide excision repair, damage is recognized, two incisions are made flanking a DNA
lesion, and residues are replaced by repair synthesis. A set of proteins required for repair of most lesions
is RPA, XPA, TFIIH, XPC-hHR23B, XPG, and ERCC1-XPF, but additional components have not been
excluded. The most complex and difficult to analyze factor is TFIIH, which has a 6-subunit core (XPB,
XPD, p44, p34, p52, p62) and a 3-subunit kinase (CAK). TFIIH has roles both in basal transcription
initiation and in DNA repair, and several inherited human disorders are associated with mutations in
TFIIH subunits. To identify the forms of TFIIH that can function in repair, recombinant XPA, RPA,
XPC-hHR23B, XPG, and ERCC1-XPF were combined with TFIIH fractions purified from HeLa cells.
Repair activity coeluted with the peak of TFIIH and with transcription activity. TFIIH from cells with
XPB or XPD mutations was defective in supporting repair, whereas TFIIH from spinal muscular
atrophy cells with a deletion of one p44 gene was active. Recombinant TFIIH also functioned in repair,
both a 6- and a 9-subunit form containing CAK. The CAK kinase inhibitor H-8 improved repair
efficiency, indicating that CAK can negatively regulate NER by phosphorylation. The 15 recombinant
polypeptides define the minimal set of proteins required for dual incision of DNA containing a cisplatin
adduct. Complete repair was achieved by including highly purified human DNA polymerase delta or
epsilon, PCNA, RFC, and DNA ligase I in reaction mixtures, reconstituting adduct repair for the first
time with recombinant incision factors and human replication proteins.
doi:10.1101/gad.14.3.349 
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Nucleotide excision repair of DNA
with recombinant human proteins:
definition of the minimal set of factors,
active forms of TFIIH, and modulation
by CAK
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Manuel Stucki,4 Ulrich Hu¨bscher,4 Jean-Marc Egly,2 and Richard D. Wood1,5
1Imperial Cancer Research Fund (ICRF), Clare Hall Laboratories, South Mimms, Hertfordshire EN6 3LD, UK; 2Institut de
Ge´ne´tique et de Biologie Mole´culaire et Cellulaire (IGBMC), BP163 67404 Illkirch Cedex, C.U. de Strasbourg, France;
3Biocenter Oulu and Department of Biochemistry, University of Oulu, FIN-90570 Oulu and Department of Biology,
University of Joensuu, FIN-80100 Joensuu, Finland; 4Department of Veterinary Biochemistry, University of Zurich-Irchel,
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During human nucleotide excision repair, damage is recognized, two incisions are made flanking a DNA
lesion, and residues are replaced by repair synthesis. A set of proteins required for repair of most lesions is
RPA, XPA, TFIIH, XPC–hHR23B, XPG, and ERCC1–XPF, but additional components have not been excluded.
The most complex and difficult to analyze factor is TFIIH, which has a 6-subunit core (XPB, XPD, p44, p34,
p52, p62) and a 3-subunit kinase (CAK). TFIIH has roles both in basal transcription initiation and in DNA
repair, and several inherited human disorders are associated with mutations in TFIIH subunits. To identify
the forms of TFIIH that can function in repair, recombinant XPA, RPA, XPC–hHR23B, XPG, and ERCC1–XPF
were combined with TFIIH fractions purified from HeLa cells. Repair activity coeluted with the peak of TFIIH
and with transcription activity. TFIIH from cells with XPB or XPD mutations was defective in supporting
repair, whereas TFIIH from spinal muscular atrophy cells with a deletion of one p44 gene was active.
Recombinant TFIIH also functioned in repair, both a 6- and a 9-subunit form containing CAK. The CAK
kinase inhibitor H-8 improved repair efficiency, indicating that CAK can negatively regulate NER by
phosphorylation. The 15 recombinant polypeptides define the minimal set of proteins required for dual
incision of DNA containing a cisplatin adduct. Complete repair was achieved by including highly purified
human DNA polymerase d or e, PCNA, RFC, and DNA ligase I in reaction mixtures, reconstituting adduct
repair for the first time with recombinant incision factors and human replication proteins.
[Key Words: Transcription; DNA repair; cisplatin; kinase; DNA polymerase; xeroderma pigmentosum]
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The process of nucleotide excision repair (NER) removes
lesions in DNA by locating damage, introducing inci-
sions on the damaged strand on each side of a lesion,
excising an oligonucleotide of 24–32 residues, and filling
in the gap by repair synthesis and ligation (de Laat et al.
1999). Considerable progress has been made in recent
years toward determining the core components that
carry out nucleotide excision repair in eukaryotes. In hu-
man cells, the proteins necessary for the incision reac-
tion include XPA, XPC–hHR23B complex, RPA, TFIIH,
and the nucleases XPG and ERCC1–XPF (Aboussekhra et
al. 1995; Mu et al. 1995, 1996). In the yeast Saccharomy-
ces cerevisiae, incision of UV lesions can be accom-
plished by the homologous set of proteins Rad14, Rad4–
Rad23, RPA, and TFIIH and the nucleases Rad2 and
Rad1–Rad10 (Guzder et al. 1995; He et al. 1996). Uncer-
tainties remain as to whether this list of proteins repre-
sents truly the minimal set of polypeptides involved in
incision. An additional factor in yeast is composed of the
Rad7 and Rad16 polypeptides and was designated
nucleotide excision repair factor 4 (Guzder et al. 1997). It
significantly increases incision efficiency in the yeast
system and was suggested to be either an ATP-dependent
damage recognition component (Guzder et al. 1998) or
necessary for postincision events (Reed et al. 1998).
Yeast cells with Rad7 or Rad16 mutations show little
repair of pyrimidine dimers in nontranscribed DNA
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strands (Verhage et al. 1994), and extracts have much
diminished repair in vitro (Wang et al. 1997). During re-
constitution of NER with UV-irradiated DNA, using
Escherichia coli DNA polymerase I to perform damage
dependent DNA synthesis, we found an additional factor
designated IF7 that significantly stimulated repair
(Aboussekhra et al. 1995). Furthermore, the UV–DDB
protein complex, defective in xeroderma pigmentosum
group E, is necessary in cells for efficient repair of cy-
clobutane pyrimidine dimers in nontranscribed DNA
(Hwang et al. 1999). Another factor with a marked effect
on yeast NER in vivo is the MMS19 gene product, which
appears to activate TFIIH for repair (Lauder et al. 1996;
Lombaerts et al. 1997). So far, experiments to reconsti-
tute the NER incision reaction have used a mixture of
recombinant components and proteins purified from hu-
man cell lysates. This has left open the possibility that
unidentified factors copurified with some of the compo-
nents required for the core repair reaction. To reach a
more definitive conclusion, we set out here to assemble
the dual incision reaction exclusively with recombinant,
highly purified components including TFIIH.
TFIIH is remarkable in that it functions both in basal
transcription initiation of mRNA as well as in nucleo-
tide excision repair (Svejstrup et al. 1996; de Laat et al.
1999). Mammalian TFIIH includes a 6-subunit core
(XPB, XPD, p62, p52, p44, and p34) and three additional
components (Cdk7, cyclin H, and MAT1). The latter sub-
units comprise the CDK-activating kinase (CAK) com-
plex, which phosphorylates the carboxy-terminal do-
main of RNA polymerase II during transcription initia-
tion (Svejstrup et al. 1996). The TFIIH helicase subunits
XPB and XPD are responsible for catalyzing the open
complex formation that takes place around a promoter
during transcription initiation and around a lesion dur-
ing NER (Evans et al. 1997b; Mu et al. 1997; Tirode et al.
1999; Winkler et al. 2000). Particular mutations in XPB
and XPD lead to different human syndromes with a sur-
prising range of photosensitivities, cancer susceptibili-
ties, and developmental abnormalities (Taylor et al.
1997; Botta et al. 1998; de Laat et al. 1999). These include
xeroderma pigmentosum (XP), Cockayne syndrome (CS),
and trichothiodystrophy (TTD).
An outstanding question is which forms of the tran-
scription-repair complex TFIIH are active in repair. Evi-
dence exists that in yeast there are interchangeable
TFIIH forms with different principal tasks, one form con-
taining CAK that works mainly in transcription and an-
other without CAK components for repair (Svejstrup et
al. 1995). Depending on the method used to isolate the
TFIIH complex from human cells, differences in the sub-
unit composition can be observed, and some free CAK
kinase complex may exist (Feaver et al. 1994; Adam-
czewski et al. 1996; Rossignol et al. 1997). By taking
advantage of the recent preparation of recombinant
TFIIH (Tirode et al. 1999) it is possible to clearly deter-
mine whether the 6- and 9-subunit forms of TFIIH are
both functional in repair. Moreover, the activity of TFIIH
purified from cells containing mutations in different
subunits can be assessed in a defined system. Finally, we
have asked whether all of the recombinant damage rec-
ognition and incision components can be combined with
highly purified human DNA synthesis proteins to
achieve complete repair.
Results
Dual incision with recombinant factors
and TFIIH fractions from HeLa cells
To monitor the dual incision reaction of NER, we used a
closed-circular plasmid containing a single 1,3 intra-
strand d(GpTpG) cisplatin–DNA cross-link. This DNA
was combined with the purified recombinant proteins
shown in Figure 1A. XPA, heterotrimeric RPA, and
ERCC1–XPF complex were produced in E. coli, whereas
XPG and XPC–hHR23B complex were produced in insect
cells.
To define the form of TFIIH active in repair and to
assess the need for any further incision proteins, these
five recombinant factors were incubated with DNA con-
taining the cisplatin lesion and TFIIH purified from
HeLa cells through various steps as outlined in Figure
2A. NER activity was followed by direct end-labeling of
the oligonucleotides produced by dual incision.
Throughout the purification procedure, TFIIH activity
was followed by assaying for transcription initiation ac-
tivity, helicase and ATPase activities, and immunoblot-
ting for known TFIIH components (Gerard et al. 1991;
Marinoni et al. 1997).
TFIIH purified from HeLa cells over four chromato-
graphic steps, TFIIH Hep fr. IV, is active in NER in com-
bination with the other purified components (Fig. 2B,
first two lanes). Fraction IV was subjected to two further
HPLC purification steps, a phenyl-5PW and a hydroxy-
apatite column (Fig. 2A). TFIIH purified over five chro-
matographic steps, TFIIH Phe fr. V, was also active in
transcription and in dual incision formation. The peak of
protein, detected by immunoblotting, coincides with
both activities (Fig. 2B). For NER assays, we found it
particularly important to use TFIIH fractions that were
as concentrated as possible.
Fraction V was purified further through a hydroxyapa-
tite column, yielding a highly purified TFIIH Hap fr. VI
(Fig. 1A). NER activity of fraction VI also peaked in the
same fraction as transcription activity (Fig. 2C). Indi-
vidual omission of any of the other factors (Fig. 3) abol-
ished repair, showing that the reaction is totally depen-
dent on the addition of RPA, XPA, XPC–hHR23B, XPG,
and ERCC1–XPF and that these repair factors are not
present in the TFIIH Hap fr. VI.
Dual incision with recombinant TFIIH
The above results with TFIIH purified from HeLa cells
did not rule out the possibility that another polypeptide
is needed for the reaction and copurifies with TFIIH.
TFIIH Hap fr. VI, for example, still contains some un-
known polypeptides detectable by silver staining (Fig.
Arau´jo et al.
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1A), and as outlined in the introductory section there are
suggestions that additional factors may be involved.
To further define the components involved in the dual
incision stage of NER, two different recombinant TFIIH
complexes were produced in insect cells. A 9-subunit
TFIIH containing XPB, XPD, p62, p52, p44, p34, cdk7,
cyclin H, and MAT1 was designated rIIH9, and TFIIH
lacking the latter three CAK subunits was designated
rIIH6. The p44 and cyclin H subunits were His-tagged
(Tirode et al. 1999). Both complexes were purified to ho-
mogeneity over a heparin–Sepharose column and a metal
chelate affinity column (Fig. 1B) and are active in tran-
scription initiation, rIIH9 having a higher transcription
activity than rIIH6 due to the presence of the CAK com-
ponents (Tirode et al. 1999).
We found that both rIIH9 (Fig. 4, lanes 4–6) and rIIH6
(Fig. 4, lanes 7–9) are active in NER. This shows that
although TFIIH containing the CAK subcomplex func-
tions in repair, CAK is not needed for dual incision for-
mation in vitro. The concentration of these two com-
plexes is approximately the same as measured by immu-
noblotting (Fig. 1B), but the response of the reaction
appeared to be nonlinear in terms of the amount of TFIIH
added (Fig. 4). For this reason, and because of the differ-
ent purification schemes and possible post-translational
modifications, a direct comparison with the activity of
native TFIIH cannot be made confidently. However, the
possibly higher activity attained with rIIH6 than with
rIIH9 suggested that the presence or activity of the CAK
subunits might have an inhibitory effect on the NER
reaction.
Stimulation of NER by inhibition of CAK activity
To directly examine the influence of CAK subunits on
NER, recombinant CAK complex (rCAK) was produced
in insect cells as described (Rossignol et al. 1997). We
tested the activity of TFIIH complexes containing 6 sub-
units (rIIH6) with and without the addition of rCAK.
Under the conditions used in this assay, there were no
detectable differences in the NER activity of TFIIH upon
adding CAK (Fig. 5A, lanes 3–5). We did notice, however,
a significant effect of CAK when an ATP-regenerating
system was included in reaction mixtures. Such an ATP-
regenerating system is not necessary when using purified
proteins (Fig. 5A), but we often include it in reaction
mixtures because it is needed for optimal activity when
using cell extracts and cruder fractions (Wood et al.
1988). With an ATP-regenerating system present, addi-
tion of CAK to rIIH6 inhibited the reconstituted NER
reaction (Fig. 5A, lanes 6–8). This suggested that the
higher steady-state levels of ATP maintained by regen-
eration might lead to an inhibitory effect of CAK kinase,
by phosphorylating a component of the reaction.
Using these conditions we tested a chemical inhibitor
of CAK kinase activity, H-8. This isoquinoline sulfon-
amide derivative inhibits the kinase activity of cdk7 and
its phosphorylation of the RNA Pol II carboxy-terminal
domain during transcription (Dubois et al. 1994). This
inhibitor was used in dual incision assays with various
TFIIH fractions, in the presence of an ATP-regenerating
system. Addition of H-8 to reactions containing TFIIH
Hep fraction IV increased its activity in NER by about
Figure 1. Purified human proteins for NER. (A) Incision factors (top line) and repair synthesis factors (bottom line). PCNA, Lig1, and
all incision factors are recombinant polypeptides except for TFIIH Hap fr. VI. The XPA, RPA, XPG, PCNA, and Lig1 gels were stained
with Coomassie blue and the others with silver. Asterisks represent identified subunits of human RFC, Pol d, and Pol e. (B) Recom-
binant TFIIH. Silver-stained gels (left) and immunoblots (right); equivalent amounts of rIIH6 or rIIH9 were loaded. The six core
subunits are present in similar amounts in the two preparations, and the CAK subunits in rIIH9 appear to be roughly stoichiometric
with the core subunits.
Human DNA repair with recombinant TFIIH
GENES & DEVELOPMENT 351
 on May 15, 2006 www.genesdev.orgDownloaded from 
threefold (Fig. 5B, lanes 7–10). H-8 did not increase the
NER activity when this fraction IV TFIIH was used in
reaction mixtures without an ATP-regenerating system
(Fig. 5B, lanes 2–5). In reaction mixtures with the purest
TFIIH fraction from HeLa cells (TFIIH Hap fr. VI), addi-
tion of increasing amounts of H-8 could stimulate repair
by up to fivefold (Fig. 5D, lanes 2–5). Addition of 100 µM
H-8 to reactions containing rIIH6 and rCAK overcame
some of the inhibition caused by addition of the kinase
complex (Fig. 5A, lane 9). When TFIIH was used that was
depleted of CAK subcomplex (Rossignol et al. 1997), H-8
did not stimulate repair, even with ATP regeneration
(Fig. 5C). These results indicate that NER activity can be
partially inhibited by CAK if ATP concentration is con-
tinually maintained.
Figure 3. Dual incision with highly purified TFIIH from hu-
man cells. NER was performed in the presence of recombinant
RPA, XPA, XPC–hHR23B, XPG, ERCC1–XPF, and TFIIH fr. IV
or fr. VI as indicated. Repair factors were individually omitted as
shown. Amounts of TFIIH used were 2 µl of Hap fr. VI (lanes
2–7), 1.5 µl of Hep fr. IV (lane 1), and 2 µl of Hap fr. VI from a
different purification (lane 8); TFIIH Hap fr. VI is fraction 6 from
Fig. 2C.
Figure 4. Dual incision reconstituted with recombinant pro-
teins: Recombinant TFIIH is active in NER. Different amounts
of rIIH6 and rIIH9 were used in a nucleotide excision repair
assay containing all the recombinant proteins needed for dual
incision formation, as indicated. The TFIIH Hep fr. IV lane used
1.5 µl of fraction, and the HeLa lane used 20 µg of whole cell
extract protein.
Figure 2. Transcription and NER activi-
ties of TFIIH copurify. (A) Scheme for
TFIIH purification from HeLa cells; TFIIH
Hep is the result of step IV, heparin–HPLC
and TFIIH Hap is the result of step VI, hy-
droxyapatite–HPLC. (B) (Top panel) In
vitro runoff transcription assays (Tirode et
al. 1999), using 1 µl of each fraction;
(middle panel) 5 µl of each step V fraction
was separated by 10% SDS-PAGE and im-
munoblotted against the three indicated
subunits of TFIIH; (bottom panel) 3 µl of
each step V fraction was used in a nucleo-
tide excision repair assay containing all
the recombinant proteins needed for dual
incision formation (except TFIIH); 1.5 µl of
TFIIH Hep fr. IV was used where indi-
cated. Only the area of the gel containing
NER excision products is shown. (C) As in
B, for step VI TFIIH fractions. (M) 35- and
27-nucleotide molecular weight markers
from a labeled MspI digest of pBR322.
Arau´jo et al.
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NER activity of purified TFIIH
containing mutated subunits
In view of the association with human syndromes it was
important to take advantage of the reconstituted NER
system and examine the activity of TFIIH purified from
cell lines carrying alterations in various subunits. In ad-
dition to the association of XPB and XPD with the dis-
orders XP, CS, and TTD, the human syndrome spinal
muscular atrophy (SMA) is also connected with alter-
Figure 5. Role of CAK in dual incision formation. (A) rIIH6 (2 µl) was tested in a dual incision assay together with increasing amounts
of rCAK in the presence (lanes 6–9) or absence (lanes 1–5) of an ATP-regenerating system. The effect of H-8 in the presence of CAK
was measured by adding the inhibitor to a final concentration of 100 µM (lanes 3,7). Data were normalized to the amount of repair
obtained in reaction mixtures containing TFIIH Hep fr. IV instead of rIIH6. (B) TFIIH Hep fr. IV (1.5 µl) was tested for dual incision
formation in the presence (lanes 6–10) or absence (lanes 1–5) of the same ATP-regenerating system as in A; increasing amounts of H-8
kinase inhibitor were added as indicated. (C) TFIIH purified from HeLa cells without the CAK subunit [TFIIH (−CAK), 2 µl] was tested
in a dual incision assay in the presence of ATP-regenerating system. TFIIH (−CAK) was prepared by disrupting TFIIH complex with
buffer containing 1.2 M KCl and depleting the CAK by immunopurification with a cdk7 antibody (Rossignol et al. 1997), and so is less
concentrated than TFIIH Hep fr. IV. Increasing amounts of H-8 were added as indicated (lanes 4–6); 1 µl of rCAK was added to a reaction
mixture in the absence of H-8 (lane 7). (D) TFIIH Hap fr. VI (1.5 µl) was tested in a dual incision assay in the presence of the
ATP-regenerating system and increasing amounts of H-8 as indicated (lanes 3–5). In all panels 1.5 µl of Hep fr. IV was used. Quanti-
fication was done on a PhosphorImager with ImageQuant. The density of the bands corresponding to the 26- to 30-mer products was
quantified and divided by the value corresponding to the reactions performed in the presence of TFIIH Hep fr. IV to give the relative counts
plotted in the graph.
Human DNA repair with recombinant TFIIH
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ations in a TFIIH subunit gene. The p44 gene is dupli-
cated in the human chromosome 5q13 region. The more
telomeric of the genes (p44t) is located in a region asso-
ciated with SMA, whereas the more centromeric (p44c)
is not. The two p44 gene products differ by three amino
acids (Burglen et al. 1997; Tirode et al. 1999). The inter-
action of p44 with XPD was shown to be important for
helicase activity (Coin et al. 1998).
To analyze the activity of TFIIH containing known
mutations, the complex was immunopurified using an
antibody against the p44 subunit (Coin et al. 1999). The
activity of TFIIH from the repair-proficient cell lines
HeLa and MRC5 [an SV40-transformed human fibro-
blast, e.g., see Mackenney et al. (1997)] was compared
with TFIIH from an XP-B cell line, an XP-D cell line, a
TTD group A cell line, and two cell lines derived from
patients with SMA.
As expected, TFIIH purified from HeLa or MRC5 cells
was active in dual incision (Fig. 6, lanes 3,5). TFIIH from
the XP-B cell line GM2252 (patient XP11BE) was com-
pletely defective in dual incision (Fig. 6, lane 10),
whereas TFIIH from GM1855, a cell line derived from
the asymptomatic mother of patient XP11BE (Hwang et
al. 1996), was active in NER (Fig. 6, lane 9). TFIIH from
HD2 cells with an XPD mutation supported only a very
low level of NER (Fig. 6, lane 6).
The activities of TFIIH from RA cells containing only
the p44c subunit (TFIIH p44c, Fig. 6, lane 7) and a TFIIH
from DJ cells containing both p44t and p44c [TFIIH
p44(t+c), Fig. 6, lane 8] were tested. TFIIH activity in
NER was not affected by the absence of p44t. Finally, we
examined repair in TFIIH from cells of TTD1BR, in the
TTD-A group. Reactions containing TFIIH from
TTD1BR cells formed low levels of dual incisions (Fig. 6,
lane 4), consistent with what was observed previously
with whole cell extract from TTD1BR (Evans et al.
1997b). Implications of these results are discussed below.
Complete reconstitution of repair synthesis
with purified human factors
Nucleotide excision repair synthesis has been examined
with UV-irradiated DNA and a mixture of proteins pu-
rified from HeLa cells, bacteria, and insect cells, and
DNA polymerase components purified from calf thymus
(Aboussekhra et al. 1995). It was found that calf thymus
DNA Pol e could function in repair in conjunction with
the recognition–incision proteins. The availability of
highly purified recombinant incision components allowed
us to determine whether these proteins could be combined
with repair synthesis factors to obtain full repair. Instead of
using UV-irradiated DNA containing a mixture of lesions,
we used DNA containing a single, specifically located cis-
platin lesion. For DNA polymerase components, we used
only highly purified human enzymes. Finally, we checked
systems using both DNA Pol d and Pol e. Although model
studies have suggested that either polymerase may fill
NER-generated incision gaps (Shivji et al. 1995), it was pos-
sible that only one of the polymerases would function in a
highly defined coupled system.
For this purpose the same DNA molecule containing a
single adduct was used as in the incision assays pre-
sented above, but reaction mixtures included a 32P-la-
beled deoxynucleotide so that patches would be radiola-
beled during repair synthesis. Cleavage of the closed cir-
cular M13 containing the cisplatin adduct with BstNI
restriction enzyme generates a 33-nucleotide fragment
that includes the repair site and several larger fragments
(Moggs et al. 1996). Synthesis arising specifically from
filling the 24- to 32-nucleotide gap during NER should be
largely confined to the 33-nucleotide fragment (labeled C
in Fig. 7), with some specific synthesis in the 68-nucleo-
tide fragment (labeled B in Fig. 7) because some mapped
58 incision sites fall within this fragment (Fig. 7, top).
To test for repair synthesis activity, all of the proteins
anticipated to be needed for NER were combined in the
same 12.5-µl volume. The reaction mixtures included
recombinant RPA, XPA, XPC–hHR23B, XPG, ERCC1–
XPF, TFIIH (with 6 or 9 subunits), PCNA, DNA ligase I,
with RFC and human DNA Pol d or Pol e purified from
human cells (Fig. 7). Both Pol d and Pol e could function
in repair. Activity was observed with TFIIH purified
from HeLa cells (Fig. 7 lanes 2,3,9,10), as well as with
6-subunit recombinant TFIIH (Fig. 7, lanes 6,13) and 9-sub-
unit recombinant TFIIH (Fig. 7, lanes 7,14). No repair was
observed when TFIIH was omitted (Fig. 7, lanes 1,8). Reac-
tion mixtures with Pol d also included FEN1 (DNase IV), as
this was found useful in limiting strand-displacement dur-
ing NER synthesis (Shivji et al. 1995). Under these condi-
tions (~ 70 mM salt), both the Pol d and Pol e reactions re-
quired both PCNA (Fig. 7, lanes 5,12) and the ATP-depen-
dent PCNA loading factor RFC (Fig. 7, lanes 4,11).
Figure 6. NER activity of TFIIH containing mutations in dif-
ferent subunits. TFIIH samples from repair-proficient cell lines
(MRC5, HeLa, and GM1855, heterozygous normal parent of
XP11BE), XP-B (GM2252, patient XP11BE), HD2 (XP-D muta-
tion R683W), TTD-A (TTD1BR), SMA line RA (TFIIH p44c), and
SMA line DJ [TFIIH p44(t+c)] were tested for dual incision ac-
tivity in combination with the other recombinant core incision
components as indicated. The TFIIH concentration of each
sample was estimated by immunoblotting (Coin et al. 1999),
and equivalent amounts of the different preparations were used
in the incision assays.
Arau´jo et al.
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Discussion
Minimal sets of human proteins for dual incision
and repair synthesis
To unequivocally identify the minimum number of fac-
tors involved in the dual incision reaction of NER, we
used exclusively recombinant proteins in conjunction
with a specific and sensitive method that detects dual
incision in a plasmid containing a single cisplatin lesion.
As recombinant RPA, XPA, XPC–hHR23B, XPG, and
TFIIH complex were sufficient for the reconstitution of
the first stage of NER, the conclusion can be reached that
only these six factors are needed. These comprise 15 or
18 polypeptides, depending on whether TFIIH with CAK
subunits is used. To date, this is the most definitive way
to rule out the participation of additional essential fac-
tors in the NER reaction on naked DNA in vitro. This
does not exclude roles for other stimulatory proteins that
are likely to be needed in cells, such as MMS19, UV–
DDB, homologs of Rad7 and Rad16, or enzymes yet to be
identified. Some factors may, for example, assist with
damage recognition in chromatin.
In addition, we reconstituted the complete NER repair
synthesis reaction by combining these recombinant in-
cision factors for the first time with recombinant and
highly purified human DNA polymerase components.
Overall the full repair reaction (dual incision plus repair
synthesis) can be achieved in vitro by 10 components,
many with multiple subunits: RPA (involved in both
steps), XPA, XPC–hHR23B, XPG, ERCC1–XPF, TFIIH
complex (with 6 or 9 subunits), DNA Pol d or Pol e, RFC,
PCNA, and DNA ligase I (and FEN1 for reaction mix-
tures including DNA Pol d). Repair synthesis occurred
on a singly adducted DNA substrate with all proteins in
the same reaction mixture, indicating that no additional
factor is required for coupling repair synthesis with dual
incision. Repair synthesis under these reaction condi-
tions depends on PCNA for both DNA Pol d and Pol e,
consistent with previous studies using model DNA sub-
strates containing short gaps (Podust and Hu¨bscher 1993;
Shivji et al. 1995, 1998). The human DNA Pol e prepa-
ration used here contained a full-length 261-kD catalytic
subunit and a 59-kD small subunit (Fig. 1A). This is in
contrast to most previous work with the enzyme, which
has been done with preparations containing a stable 140-
kD fragment of the catalytic subunit of the enzyme
(Aboussekhra et al. 1995; Chui and Linn 1995). With
both polymerases, the RFC complex that loads PCNA
onto DNA in an ATP-dependent reaction was also re-
quired for repair synthesis on this circular template.
Active 6- and 9-subunit forms of TFIIH
and modulation of repair activity by CAK
In a complementation assay for TFIIH repair activity us-
ing five recombinant incision factors, we found that re-
pair activity eluted in a peak coinciding with TFIIH pro-
tein and transcription activities. This suggested that the
same form of TFIIH can function in both transcription
and in NER. In support of this, we found that a 9-subunit
form of recombinant TFIIH containing the CAK sub-
units is active in dual incision. However, CAK is dis-
pensable for NER in vitro, as shown here with the 6-sub-
unit form of recombinant TFIIH and as shown by
complementation of S. cerevisiae cell lysates (Svejstrup
et al. 1995) or of partially purified human proteins (Mu et
Figure 7. Reconstitution of incision and repair synthesis with
recombinant and human purified factors. (Top) Schematic rep-
resentation of the DNA substrate containing a single 1,3 intra-
strand d(GpTpG) cisplatin cross-link. The sizes of the fragments
generated by BstNI restriction digestion are shown underneath.
Arrows indicate mapped positions of NER incisions. (Bottom)
Reconstitution of repair synthesis on a plasmid containing a
single cisplatin adduct. Different TFIIH preparations were used
in reactions performed in the presence of Pol d (lanes 1–7) or Pol
e (lanes 8–14); lanes 2 and 9 contain 1.5 µl of TFIIH Hep fr. IV,
lanes 3–5 and 10–12 contain 3 µl of TFIIH Hap fr. VI, lanes 6 and
13 contain 3 µl of rIIH6, and lanes 7 and 14 contain 3 µl of rIIH9.
Reactions in lanes 4 and 11 were done in the absence of RFC,
and reactions in lanes 5 and 12 were done in the absence of
PCNA.
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al. 1996). In yeast, evidence has been presented that
TFIIH without the corresponding CAK subunits may be
specialized for repair, as it is found physically associated
with some of the other NER components in a preas-
sembled repairosome (Svejstrup et al. 1995). Definitive
evidence for a corresponding high molecular weight
functional association in mammalian cells is presently
lacking (Arau´jo and Wood 1999).
TFIIH easily separates into several subcomplexes upon
purification, and it is uncertain which forms are the
natural ones in cells and which are created during puri-
fication. Nine-subunit TFIIH containing CAK can be iso-
lated with gentle methods, but forms without the CAK
subunits are also found during purification, particularly
a 5-subunit complex without the CAK and XPD subunits
(Drapkin et al. 1996; Reardon et al. 1996; Rossignol et al.
1997). XPD helicase activity is necessary for nucleotide
excision repair (Winkler et al. 2000) and TFIIH lacking
the XPD subunit is inactive (S.J. Arau´jo, R.D. Wood, and
J.M. Egly, unpubl.). It remains to be shown whether the
6- or 9-subunit form, or both, actually participate in NER
in vivo. Microinjection of an anti-cdk7 antibody can in-
hibit NER in cells (Roy et al. 1994), suggesting either
that the 9-subunit version normally participates in repair
or that the antibody inhibits its conversion into a form
active in repair (Svejstrup et al. 1995).
We made the unexpected finding that although the
physical presence of the CAK subunits is not necessarily
detrimental to NER, inclusion of CAK inhibited repair
when reaction mixtures included an ATP regenerating
system. Consistent with this effect, inhibition of CAK
activity by H-8 kinase inhibitor could stimulate repair
reactions and partially reverse the inhibitory effect of
CAK. It seems likely that when ATP levels are suffi-
ciently high, the CAK inhibits repair by phosphorylating
one or more components of the reaction. It is clear that
excessive phosphorylation can inhibit repair, as shown
by the fact that inhibitors of protein phosphatases caused
dramatic suppression of repair activity in cell extracts
(Ariza et al. 1996). The targets of such kinase inhibition
are unknown; a potential substrate is the XPG protein,
which is readily phosphorylated (S.J. Arau´jo and R. Ariza,
unpubl.). It is noteworthy that the kinase activity of
TFIIH decreases after UV irradiation of mammalian
cells, suggesting that cells may have a mechanism to
suppress CAK activity when DNA repair is urgently re-
quired (Adamczewski et al. 1996). The present result em-
phasizes the potential for regulation of NER by phos-
phorylation. Because CAK is needed for transcription but
not for repair, and can even inhibit repair under some
conditions, it is tempting to speculate that a 6-subunit
form may be specialized for NER. However, we find that
essentially all TFIIH in cell extracts is associated with
CAK (S.J. Arau´jo and R. Wood, unpubl.).
XPB, XPD, and p44 TFIIH mutants
in the defined repair system
The defined in vitro system provides an ideal tool to
study the influence of different TFIIH mutations on dual
incision formation. To initiate such studies, TFIIH was
immunopurified from cell extracts containing known
naturally occuring mutations in various subunits. The
XP individual XP11BE was the first XP-B patient identi-
fied and was a severely affected patient with both XP and
Cockayne syndrome. The causative mutation in XP11BE
alters the carboxy-terminal 42 amino acid residues of
XPB, outside the conserved helicase domains (Weeda et
al. 1990). The transcription activity of XP11BE TFIIH is
partially impaired, showing ~ 15% of the activity dis-
played by normal TFIIH (Coin et al. 1999). NER experi-
ments carried out with cell extracts from XP11BE
showed that this TFIIH still functions to form an open
bubble intermediate and a normal 38 incision, but no 58
incision is carried out (Evans et al. 1997b). We found that
XP11BE TFIIH could not support dual incision in the
reconstituted system, consistent with its specific defect
in 58 incision activity.
The immortalized cell line HD2 was derived by fusing
XP102LO XP-D cells with HeLa cells and selection of a
hybrid clone with low repair capacity (Johnson et al.
1985). XP102LO cells carry a R683W mutation in one
allele, and both an L461V substitution and a deletion of
amino acids 716–730 in another allele (Takayama et al.
1995). The causative mutation in HD2 is assumed to be
R683W as this mutation determines the phenotype in
patient XP102LO (Taylor et al. 1997). The R683W amino
acid substitution is in a region of the XPD gene in which
many mutations are present (Taylor et al. 1997). This
region of the protein is involved in the interaction be-
tween XPD and p44 (Coin et al. 1998), and there is a
lower fraction of XPD subunit in HD2 TFIIH, leading to
~ 50% of normal transcription assay. We observed a low
level of dual incision in reactions with HD2 TFIIH. Re-
pair in HD2 cells was originally measured by survival
after UV irradiation and by UV-induced unscheduled
DNA synthesis in hybrids with known XP-D cell lines.
Both indices were reported to be slightly higher than that
of the XP-D parental cell line XP102LO (Johnson et al.
1985). It seems plausible that residual activity might be
contributed by a low level of expression of a normal
TFIIH allele in the HD2 hybrid.
In the SMA cell lines, the helicase activity of XPD was
shown to be normal, and TFIIH from both cell lines had
equivalent transcription activity (Coin et al. 1999). Fur-
thermore, recombinant TFIIH containing either p44c or
p44t supports transcription (Tirode et al. 1999). The data
presented here show that TFIIH containing only p44c is
also active in repair, a result consistent with the absence
of clinical symptoms related to NER in SMA patients
(Burglen et al. 1997).
The defect giving rise to TTD group A is thought to
reside in a TFIIH-associated factor, because the TTD1BR
repair defect can be complemented by microinjection of
TFIIH complex (Stefanini et al. 1993; Vermeulen et al.
1994). However, unlike other TTD cell lines, mutations
in a known TFIIH subunit have not been found in
TTD1BR. The present results are consistent with this, in
that TFIIH from TTD1BR cells is capable of functioning
in NER. However, the TFIIH from TTD1BR had a lower
Arau´jo et al.
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activity. The reason for this is still unknown but could
be caused, for example, by an altered post-translational
modification such as phosphorylation in TTD-A cells.
The ability to specifically measure TFIIH activity in a
pure system, as described here, coupled with the means
to distinguish defects in open complex formation and 38
and 58 incisions (Evans et al. 1997b; Constantinou et al.
1999) opens the way to dissection of the defects in other
naturally occurring and directed mutants.
Materials and methods
Proteins
His-tagged recombinant XPA protein was produced in E. coli,
purified as described (Jones and Wood 1993), and had a concen-
tration of 450 µg/ml. Recombinant heterotrimeric RPA was
produced in E. coli, purified as described (Henricksen et al.
1994), and had a concentration of 500 µg/ml. Recombinant
ERCC1–XPF complex was produced in E. coli, purified (Sijbers
et al. 1996), and had a concentration of 20 µg/ml. Recombinant
XPG protein was produced in insect cells, purified to homoge-
neity as described (Evans et al. 1997a), and had a concentration
of 45 µg/ml. Recombinant XPC–hHR23B complex was ex-
pressed and purified from insect cells (Masutani et al. 1997) and
the final concentration of the complex was 15 µg/ml. TFIIH was
purified from HeLa cells (Marinoni et al. 1997) or in recombi-
nant form from insect cells (Tirode et al. 1999).
DNA Pol d and RFC were purified from HeLa cells (Weiser et
al. 1991; Hu¨bscher et al. 1999). Human Pol e was purified as
outlined (Syva¨oja and Linn 1989), except that the glycerol gra-
dient centrifugation was performed in the presence of 20 mM
potassium phosphate (pH 7.5). Recombinant DNA ligase I
(Mackenney et al. 1997) and DNase IV (FEN1) (Robins et al.
1994) were provided by T. Lindahl (ICRF, UK). The recombinant
PCNA was purified from E. coli cells (Biggerstaff and Wood
1999) and had a final concentration of 600 µg/ml.
Nucleotide excision repair–dual incision assay
Covalently closed circular DNA containing a single 1,3-intra-
strand d(GpTpG) cisplatin–DNA crosslink (Pt–GTG) was pre-
pared as described (Shivji et al. 1999). Repair was carried out in
8.5 µl reaction mixtures for the fully defined reactions. Reac-
tions were carried out in a buffer containing 45 mM HEPES–
KOH (pH 7.8), 70 mM KCl, 5 mM MgCl2, 1 mM DTT, 0.3 mM
EDTA, 10% glycerol, 2.5 µg of BSA, and 2 mM ATP. Where
indicated, reactions were supplemented with an ATP-regener-
ating system consisting of 40 mM phosphocreatine (di-Tris salt)
and 0.5 µg of creatine phosphokinase (type I). Each reaction
contained 50 ng of RPA, 22.5 ng of XPA, 10 ng of XPC–hHR23B
complex, 50 ng of XPG, 20 ng of ERCC1–XPF complex, and
either 1.5 µl of HeLa TFIIH [Hep fr. IV (Marinoni et al. 1997)] or
the indicated amounts of other TFIIH fractions. Following pre-
incubation for 10 min at 30°C, 50 ng Pt–GTG was added and
reactions were continued for 90 min at 30°C. Rapid freezing
stopped the reactions. 6 ng of an oligonucleotide complemen-
tary to the excised DNA fragment (and containing four extra G
residues at the 58 end) was annealed to the excision products.
Sequenase v. 2.0 polymerase (0.1 unit) and 1 µCi of [a-32P]dCTP
were used to add four radiolabeled C residues to each excision
product. Products were separated on a denaturing 14% poly-
acrylamide gel and visualized by autoradiography as described
(Shivji et al. 1999).
Nucleotide excision repair–repair synthesis assay
Single lesion (Pt–GTG) plasmid was used as in the previous
section for the formation of dual incisions. All reaction mix-
tures (12.5 µl) were supplemented with 40 mM phosphocreatine
(di-Tris salt) and 0.5 µg of creatine phosphokinase (type I), and
synthesis was performed in the presence of 2 µCi of [a-32P]dCTP
(3000 Ci/mmole), 5 µM dCTP, and of 20 µM of each: dATP,
dGTP, and TTP. Repair synthesis was performed simulta-
neously with the incision step in fully reconstituted reactions.
Proteins involved in the dual incision step are in the same
amounts as described above and proteins involved in the syn-
thesis step were 60 ng of recombinant PCNA, 50 ng of recom-
binant DNA ligase I, 0.8 unit of RFC, and 0.9 unit of Pol e or 0.1
unit of Pol d. One RFC unit is defined as the incorporation of 10
pmoles of dNMP into acid-insoluble material in 60 min at 37°C
in an RFC dependent replication reaction containing primed
circular DNA, RP-A, Pol d, and PCNA (Hu¨bscher et al. 1999);
0.8 unit corresponds to 0.5 µl of the RFC used. Reactions per-
formed with Pol d also contained 15 ng of recombinant FEN1.
Following preincubation for 15 min at 30°C, 50 ng of Pt–GTG
was added and reactions were continued for 3 hr at 30°C. DNA
was digested in 15-µl reactions with 5 units of BstNI at 60°C for
2 hr prior to electrophoresis in denaturing 14% polyacrylamide
gels as described (Shivji et al. 1998).
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